 |
|
|
| |
COMPARATIVE EFFICACY AND SAFETY OF A COMBINATION THERAPY OF DOLUTEGRAVIR AND LAMIVUDINE VS 3-DRUG ANTIRETROVIRAL REGIMENS IN TREATMENT-NAIVE HIV-1 INFECTED PATIENTS AT 96 WEEKS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
|
| |
| |
IAC 2020 Virtual SF
Reported by Jules Levin
Katharina Nickel,1 Nicholas J. Halfpenny,2 Sonya J. Snedecor,3 Yogesh Suresh Punekar4
1Pharmerit International, Berlin, Germany; 2Pharmerit International, Rotterdam, the Netherlands; 3Pharmerit International, Bethesda, MD, USA; 4ViiV Healthcare, London, UK
|
| |
|
|
|
|
|
